In vivo functional imaging using receptor-binding radiopharmaceuticals. Technetium 99m-galactosyl-neoglycoalbumin as a model.
Stadalnik
R C
RC
Division of Nuclear Medicine, University of California Davis Medical Center, Sacramento 95817.
Kudo
M
M
Eckelman
W C
WC
Vera
D R
DR
D000418:Albumins; D000818:Animals; D001345:Autoradiography; D001665:Binding Sites; D003198:Computer Simulation; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008099:Liver / Q000000981:diagnostic imaging*; D008107:Liver Diseases / Q000000981:diagnostic imaging; D008113:Liver Neoplasms / Q000000981:diagnostic imaging; D015609:Organotechnetium Compounds; D011869:Radioligand Assay; D011877:Radionuclide Imaging; D012709:Serum Albumin
D000418:Albumins; D015609:Organotechnetium Compounds; D012709:Serum Albumin; C036586:technetium Tc 99m neogalactoalbumin